Home › Funds › Artia Global Partners LP › ELVN

Artia Global Partners LP position in ELVN

ENLIVEN THERAPEUTICS INC · Health Care

Artia Global Partners LP reported holding 72,100 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.7M, representing 0.68% of its reported portfolio and ranking #36 among its reported holdings. Artia Global Partners LP has disclosed ELVN holdings in 3 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)72.10K sh
Reported value held$3.66M
Portfolio Weight0.68%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's ELVN position evolved

Artia Global Partners LP first disclosed a stake in ELVN in Q4 2024 at 102,900 shares (US$2.3M). The position peaked in Q2 2026 at 72,100 shares, worth US$3.7M. Across 3 filings, Artia Global Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 72,100 shares valued at US$3.7M — an increase of 51,200 shares quarter over quarter.. Notable position changes include a 245% increase in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 102.90K $2.32M New
Q1 2026 20.90K $819.28K New
Q2 2026 72.10K $3.66M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELVN and 13F data

ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 68 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$343.9M), Polar Capital Holdings Plc (US$326.4M), Vestal Point Capital, LP (US$203.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELVN

All ELVN fund holders →

FAQ

How long has Artia Global Partners LP held ELVN?

Artia Global Partners LP has disclosed ELVN holdings in 3 of the last 7 reported quarters, going back to Q4 2024.

What is Artia Global Partners LP's current position in ELVN?

As of Q2 2026, Artia Global Partners LP holds 72.10K shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $3.66M, representing 0.68% of its reported portfolio and ranking #36.

Has Artia Global Partners LP been buying or selling ELVN?

In the latest 13F filing (Q2 2026), Artia Global Partners LP increased its position in ELVN. The position peaked in Q2 2026 at 72.10K shares.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Vestal Point Capital, LP, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.